Depression decisions — 2025

The Board denied the Veteran's claim for service connection for an acquired psychiatric disability other than PTSD, as her sleep disturbances and depression were found to be symptoms of her already service-connected PTSD.

The Board remands the claims for service connection due to a pre-decisional duty to assist error, specifically regarding TERA development and VA examinations.

The Board granted service connection for an acquired psychiatric disorder, diagnosed as major depressive disorder, recurrent, moderate, with anxious distress. The claim for a compensable rating for pseudofolliculitis barbae of the face was denied.

The Veteran was granted an initial disability rating of 70 percent for his acquired psychiatric disorder and a total disability rating based on individual unemployability.

The Board denied an increased rating for bilateral pes planus with bilateral heel pain and remanded the claims for service connection for anxiety and depression.

The Board remands the claim for service connection for major depression with psychosis to schedule a new VA examination.

The Board granted service connection for treatment purposes only under 38 U.S.C. Chapter 17 for an acquired psychiatric disorder characterized by a trauma disorder with depression, based on a medical nexus between the Veteran's in-service incurrence and current diagnosis.

The Board denied the veteran's claims for increased ratings for major depressive disorder with anxious distress and insomnia, painful right hand laceration scar, right hand laceration scar associated with underlying soft tissue damage, and hypertension.

The Board granted service connection for PTSD and restless leg syndrome, denied service connection for a respiratory disorder other than sinusitis and rhinitis, and granted an initial rating of 70 percent for depressive disorder with alcohol use disorder effective August 18, 2022.

The Board remands the claim for service connection for an acquired psychiatric disorder, to include posttraumatic stress disorder (PTSD), depressive disorder, and alcohol use disorder, due to a need to verify in-service stressors and ensure the full scope of the Veteran's claim is addressed.

The Board denied service connection for an acquired psychiatric disorder, to include PTSD, dysthymia, and unspecified depressive disorder, as the evidence did not support a current diagnosis of PTSD or a link between any claimed in-service stressors and the Veteran's current psychiatric conditions.

The Veteran's service connection for GERD was granted, while the claims for a low back disability and increased ratings for unspecified depressive disorder with anxious distress with bruxism were denied. The rating for the psychiatric condition was increased to 70 percent effective May 10, 2024.

The appeal for service connection for specific phobia with persistent depressive disorder, with major depressive episodes was dismissed as the benefit sought by the Veteran was granted in full.

The Board remands the claim for a psychiatric disorder to obtain an adequate VA medical opinion.

The Board remands the issue of entitlement to service connection for an acquired psychiatric condition, including depression, anxiety, and PTSD, as further development is needed.

The appeal for service connection for unspecified depression with anxious distress, moderate (claimed as insomnia) was dismissed. The claim for bilateral hearing loss was denied. The lumbosacral strain to include DJD and DDD was remanded.

The Board granted service connection for PTSD, depressive disorder, anxiety disorder, and unspecified bipolar and related disorder based on credible evidence of in-service stressors and continuous symptoms since service.

The Board granted service connection for major depressive disorder prior to October 18, 2024, but remanded the claim for sleep apnea due to duty-to-assist errors.

The Board granted the effective date of April 5, 2002, for the award of service connection for various disabilities.

The Veteran was granted increased ratings of 60 percent for Hepatitis C prior to September 8, 2016, and 100 percent for anxiety and depression for the entire period on review.